ScreenHub on MSN
Saccharine review: freaky, fun body horror for the Ozempic era
This review contains discussion of disordered eating, fatphobia and body dysmorphia. A great deal of cinema is about the vibe. Saccharine, Australian director Natalie Erika James’ deliberately icky ...
Targeted therapy of the ipsilesional, or “good” arm, improved motor function, including control and speed, in chronic stroke survivors with severe paresis. In a small randomized clinical trial ...
The National Institutes of Health (NIH) on Tuesday discontinued the low-dose rivaroxaban arm of its ongoing Phase 3 CAPTIVA stroke prevention trial. The primary goal of the trial is to determine if ...
The National Institutes of Health (NIH) halted a treatment arm of Bayer and Johnson & Johnson’s Xarelto (rivaroxaban) in a phase 3 stroke prevention trial after an independent committee flagged safety ...
For nearly five decades, Steven Spielberg has helped define what alien stories mean to movie audiences. Sometimes they arrive as cosmic miracles. Sometimes as existential threats. Sometimes as ...
The tech sector soared as the risk-on trade returned. Amazon said it would spend $200 on capital expenditures next year, a bullish sign for Arm and its peers. Arm's business in the data center is more ...
IN THE SEMICONDUCTOR industry, Arm is everywhere and nowhere. Designs from the British-based, American-listed, Japanese-controlled firm sit in almost all the world’s smartphones and most other ...
Barack Obama seemingly confirmed the existence of aliens in a podcast, though he later walked back his comments on Instagram. Congress has held multiple hearings on UFOs, now called UAPs, since 2023, ...
Arm Holdings is rated Buy, driven by a structural shift to Agentic AI, positioning ARM as a foundational AI infrastructure utility. ARM’s data center royalty revenue is doubling year-over-year, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results